510(k) · Cleared

Cleared

Omnican Syringe

K962084510(k) TraditionalCleared Feb 10, 1997257-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

B. Braun Medical AG · FMF Syringe, Piston

Cleared on Feb 10, 1997 as substantially equivalent to K941657 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 1994) after a 257-day review. Its family tree reaches back 1 generation to 1994. 1 later device descends from it.

Decided: Feb 10, 1997
Review: 257 days
Class: Class II
Product code: FMF
Recalls: None
Predicates: 1

Its longest line of descent runs back 1 generation to K941657 (1994). 1 later device descends from it, 1 citing it directly.

By dateBy generation

Root · 1 generation backK941657 BD Micro Fine, Ultra Fine, and Allergy SyringeBd Becton Dickinson Vacutainer Systems Preanalytic · 1994
This deviceK962084 Omnican SyringeB. Braun Medical AG · 1997
Descendant · cites it directly · 0 of its ownK983994 UnifineOwen Mumford USA, Inc. · 1999

Most influential descendants

Showing 1 of 1 · See all

K983994UnifineOwen Mumford USA, Inc. · 1999 · cites it directly0descendants

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−1	K941657	BD Micro Fine, Ultra Fine, and Allergy Syringe	Bd Becton Dickinson Vacutainer Systems Preanalytic	1994	—
0 (this device)	K962084	Omnican Syringe	B. Braun Medical AG	1997	—
+1	K983994	Unifine	Owen Mumford USA, Inc.	1999	—

Descendants by year cleared

Year cleared	Devices	With a Class I recall
1999	1	0

FIG. 1 — Lineage of K962084, 1994–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMF device

#1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.2 · 8 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K941657	BD Micro Fine, Ultra Fine, and Allergy Syringe Summary page 1 …Syringe TRADE NAME: Piston Syringe CLASSIFICATION NAME: General Hospital Class II, 80 FMF 21 CFR 880.5860 SUBSTANTIAL EQUIVALENCE1 TO: 510 (k) number Name Applicant K941657 Insulin Syringe Becton Dickinson DEVICE DESCRIPTION: In accordance with section 510(k) for the Federal Food, Drug, and Cosmet…	Bd Becton Dickinson Vacutainer Systems Preanalytic	1994	—

Also cleared against K941657: 7 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

Number	Device	Applicant	Decided	Descendants
K983994	Unifine	Owen Mumford USA, Inc.	1999	0

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

Its one ancestor has no recall.
Of its descendants, K983994 (Owen Mumford USA, Inc., 1999) has gone furthest, with 0 descendants of its own.
7 other devices also cite its predicate K941657.

How does its category compare?

All FMF devices

FMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FMF

13in 2025

2007high 24 (2022) · low 8 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMF

114in 2025

2007high 239 (2026) · low 74 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMF

19in 2023

2007high 19 (2023) · low 0 (2016)2026

Class I (19 since 2007) Class II/III not classified

Adverse event reports per year · FMF

4,181in 2025

2007high 5,874 (2021) · low 186 (2011)2025

MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	23	90	6	674
2008	9	74	11	691
2009	14	94	15	913
2010	11	130	12	679
2011	16	109	3	186
2012	9	86	6	307
2013	12	154	1	326
2014	13	84	1	244
2015	11	87	2	273
2016	12	146	0	684
2017	13	135	3	1,858
2018	8	87	2	3,952
2019	11	146	1	5,863
2020	15	107	2	5,334
2021	20	175	1	5,874
2022	24	211	2	5,233
2023	22	173	19 (18)	5,214
2024	14	130	0	5,122
2025	13	114	0	4,181
2026	9	239	2 (1)	—

What is it indicated for?

The Omnican Syringe is designed to be used for subcutaneous injection.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

https://510kreport.com/device/K962084 · printed Nov 4, 2026

Cite this page

510(k) Report. “K962084: Omnican Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K962084

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026